Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina

por Wurcel, Victoria, Scherrer, Emilie, Aguiar-Ibanez, Raquel, Altuna, Juan Ignacio, Carabajal, Fernando, Jain, Shrishti, Baluni, Gargi
Publicado 2021

Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection

por Lopez-Vinueza, Cesar, Urrego-Reyes, Juan, Gutierrez, Fredy R. S., Wurcel, Victoria, Zhang, Shujing, Jiang, Shan, Jiang, Ruixuan, Zambrano Harvey, Angela, Dhankhar, Praveen, Sawhney, Baanie, Baluni, Gargi, Jain, Shrishti, Bhadra, Debosmita
Publicado 2023